ChemicalBook >> CAS DataBase List >>β-D-Glucopyranosiduronic acid, (2R,5S,13aR)-2,3,4,5,7,9,13,13a-octahydro-7,9-dioxo-10-[[[(2,4,6-trifluorophenyl)methyl]amino]carbonyl]-2,5-methanopyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazepin-8-yl
β-D-Glucopyranosiduronic acid, (2R,5S,13aR)-2,3,4,5,7,9,13,13a-octahydro-7,9-dioxo-10-[[[(2,4,6-trifluorophenyl)methyl]amino]carbonyl]-2,5-methanopyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazepin-8-yl
- CAS No.
- 2365156-60-9
- Chemical Name:
- β-D-Glucopyranosiduronic acid, (2R,5S,13aR)-2,3,4,5,7,9,13,13a-octahydro-7,9-dioxo-10-[[[(2,4,6-trifluorophenyl)methyl]amino]carbonyl]-2,5-methanopyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazepin-8-yl
- Synonyms
- Bictegravir Impurity 9;Ambrisentan Impurity 1-d3(Ambrisentan Racemate-d3);Bictegravir Metabolite M15Q: What is Bictegravir Metabolite M15 Q: What is the CAS Number of Bictegravir Metabolite M15;β-D-Glucopyranosiduronic acid, (2R,5S,13aR)-2,3,4,5,7,9,13,13a-octahydro-7,9-dioxo-10-[[[(2,4,6-trifluorophenyl)methyl]amino]carbonyl]-2,5-methanopyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazepin-8-yl;(2S,3S,4S,5R,6S)-6-(((2R,5S,13aR)-7,9-Dioxo-10-((2,4,6-trifluorobenzyl)carbamoyl)-2,3,4,5,7,9,13,13a-octahydro-2,5-methanopyrido[1'',2'':4,5]pyrazino[2,1-b][1,3]oxazepin-8-yl)oxy)-3,4,5-trihydroxytetrahydro-2H-pyran-2-carboxylic acid
- CBNumber:
- CB99781284
- Molecular Formula:
- C27H26F3N3O11
- Molecular Weight:
- 625.51
- MDL Number:
- MOL File:
- 2365156-60-9.mol
Last updated:2022-12-21 16:56:50
β-D-Glucopyranosiduronic acid, (2R,5S,13aR)-2,3,4,5,7,9,13,13a-octahydro-7,9-dioxo-10-[[[(2,4,6-trifluorophenyl)methyl]amino]carbonyl]-2,5-methanopyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazepin-8-yl Properties
Boiling point | 945.8±65.0 °C(Predicted) |
---|---|
Density | 1.75±0.1 g/cm3(Predicted) |
pka | 2.76±0.70(Predicted) |
FDA UNII | TD2G64J9XN |
β-D-Glucopyranosiduronic acid, (2R,5S,13aR)-2,3,4,5,7,9,13,13a-octahydro-7,9-dioxo-10-[[[(2,4,6-trifluorophenyl)methyl]amino]carbonyl]-2,5-methanopyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazepin-8-yl Preparation Products And Raw materials
Raw materials
Preparation Products
β-D-Glucopyranosiduronic acid, (2R,5S,13aR)-2,3,4,5,7,9,13,13a-octahydro-7,9-dioxo-10-[[[(2,4,6-trifluorophenyl)methyl]amino]carbonyl]-2,5-methanopyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazepin-8-yl Suppliers
Global( 4)Suppliers
Supplier | Tel | Country | ProdList | Advantage | |
---|---|---|---|---|---|
Guangzhou Jiuzhi Pharmaceutical Technology Co., Ltd. | 020-89854820 | sales@jzpharma.cn | China | 1081 | 58 |
Shenzhen Roark Pharma-Tec Co., Ltd. | 13128912434 | 2880126944@qq.com | China | 2579 | 58 |
Supplier | Advantage |
---|---|
Guangzhou Jiuzhi Pharmaceutical Technology Co., Ltd. | 58 |
Shenzhen Roark Pharma-Tec Co., Ltd. | 58 |
β-D-Glucopyranosiduronic acid, (2R,5S,13aR)-2,3,4,5,7,9,13,13a-octahydro-7,9-dioxo-10-[[[(2,4,6-trifluorophenyl)methyl]amino]carbonyl]-2,5-methanopyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazepin-8-yl
Bictegravir Metabolite M15Q: What is
Bictegravir Metabolite M15 Q: What is the CAS Number of
Bictegravir Metabolite M15
Bictegravir Impurity 9
(2S,3S,4S,5R,6S)-6-(((2R,5S,13aR)-7,9-Dioxo-10-((2,4,6-trifluorobenzyl)carbamoyl)-2,3,4,5,7,9,13,13a-octahydro-2,5-methanopyrido[1'',2'':4,5]pyrazino[2,1-b][1,3]oxazepin-8-yl)oxy)-3,4,5-trihydroxytetrahydro-2H-pyran-2-carboxylic acid
Ambrisentan Impurity 1-d3(Ambrisentan Racemate-d3)
2365156-60-9
C27H26F3N3O11